General Information
Activity Information
-
Biological Activity
- Antimicrobial, Antiviral(SARS-CoV-2)
-
Target Organism
-
- [Ref.32376627]Virus:
- SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50=4.66 ± 1.565 µM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=1.738 ± 0.898 µM);
- SARS-CoV:inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC=1.13 ± 0.472 µM);
- Vesicular Stomatitis Virus (VSV):inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50>50 µM).
-
Hemolytic Activity
-
- No hemolysis information or data found in the reference(s) presented in this entry
-
Cytotoxicity
- No cytotoxicity information found in the reference(s) presented
-
Binding Target
- liposomes
Structure Information
-
Linear/Cyclic
- Linear
-
N-terminal Modification
- Free
-
C-terminal Modification
- Chol
-
Nonterminal Modifications and Unusual Amino Acids
- None
-
Stereochemistry
- L
-
Structure
- Not found
-
Structure Description
- Not found
-
Helical Wheel Diagram
-
PDB ID
- None
-
Predicted Structure
- There is no predicted structure for DRAMP29186.
Physicochemical Information
-
Formula
- C148H257N43O49
Absent Amino Acids
- CFHMPTWY
Common Amino Acids
- IN
Mass
- 3422.93
PI
- 6.26
Basic Residues
- 4
Acidic Residues
- 4
Hydrophobic Residues
- 13
Net Charge
- 0
-
Boman Index
- -5362
Hydrophobicity
- -0.126
Aliphatic Index
- 135.16
Half Life
-
- Mammalian:20 hour
- Yeast:30 min
- E.coli:>10 hour
Extinction Coefficient Cystines
- 0
Absorbance 280nm
- 0
Polar Residues
- 9
DRAMP29186
Comments Information
Mechanism of action
- The peptide was designed based on HR2 sequence lipopeptide fusion inhibitor,which showed highly potent activities in inhibiting SARS-CoV-2 S protein-mediated cell-cell fusion and pseudovirus transduction. It can also inhibit the SARS-CoV pseudovirus efficiently.
Literature Information
- ·Literature 1
-
Title
- Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.
-
Pubmed ID
- 32376627
-
Reference
- J Virol. 2020 Jul 1;94(14):e00635-20.
-
Author
- Zhu Y, Yu D, Yan H, Chong H, He Y.